Author: Su, Hao; Ma, Chengquan; Li, Hongjun
Title: Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review) Cord-id: vchke0or Document date: 2021_2_3
ID: vchke0or
Snippet: Coronavirus disease 2019 (COVID-19) has a variety of impacts on the human body. Severe acute respiratory syndrome coronavirus 2 is the pathogen that causes COVID-19. It invades human tissues through the receptor angiotensin-converting enzyme 2, resulting in an imbalance in the angiotensin II (AngII) level and upregulation of renin-angiotensin system/AngII pathway activity. Furthermore, the binding of AngII to its receptor leads to vasoconstriction, endothelial injury and intravascular thrombosis
Document: Coronavirus disease 2019 (COVID-19) has a variety of impacts on the human body. Severe acute respiratory syndrome coronavirus 2 is the pathogen that causes COVID-19. It invades human tissues through the receptor angiotensin-converting enzyme 2, resulting in an imbalance in the angiotensin II (AngII) level and upregulation of renin-angiotensin system/AngII pathway activity. Furthermore, the binding of AngII to its receptor leads to vasoconstriction, endothelial injury and intravascular thrombosis. In addition, COVID-19 may have adverse effects on male reproductive organs and a marked impact on male reproductive health. Phosphodiesterase-5 inhibitors (PDE5Is) may improve vascular endothelial function, promote testicular and systemic blood circulation and testosterone secretion and enhance epididymal function, as well as sperm maturation and capacitation. PDE5Is may also be of use in the treatment of infectious diseases by enhancing immunity and anti-inflammatory responses and improving vascular endothelial function. Based on the pharmacological mechanism of PDE5Is, they are of unique value in the fight against infectious diseases and may be effective in combination with direct antiviral drugs. The anti-infection mechanisms of PDE5Is and their roles in COVID-19 were reviewed in the present study.
Search related documents:
Co phrase search for related documents- ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- ace inhibitor and local tissue: 1
- ace inhibitor and lung function: 1, 2
- ace inhibitor and lung inflammation: 1
- ace inhibitor and lung injury: 1, 2, 3, 4
- ace inhibitor and lymphocyte count: 1
- ace receptor and activation thrombosis: 1
- ace receptor and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- ace receptor and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- ace receptor and ad disease: 1, 2, 3
- ace receptor and local tissue: 1
- ace receptor and lung function: 1, 2, 3, 4, 5, 6, 7
- ace receptor and lung inflammation: 1, 2, 3, 4, 5, 6, 7
- ace receptor and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- ace receptor and lymph node: 1
- ace receptor and lymphocyte count: 1, 2
- ace receptor and lymphocyte infiltration: 1, 2
- ace receptor and macrophage infiltration: 1
- ace renin activity and acute infection: 1
Co phrase search for related documents, hyperlinks ordered by date